diethylnitrosamine has been researched along with caudatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y; Peng, Y | 1 |
| Cui, L; Ding, W; Feng, L; Jia, X; Liu, B; Liu, D; Luo, Y; Song, J; Xia, Z; Zhang, L | 1 |
2 other study(ies) available for diethylnitrosamine and caudatin
| Article | Year |
|---|---|
Pharmacokinetics and tissue distribution study of caudatin in normal and diethylnitrosamine-induced hepatocellular carcinoma model rats.
Topics: Alkylating Agents; Animals; Carcinoma, Hepatocellular; Chromatography, Liquid; Diethylnitrosamine; Disease Models, Animal; Drugs, Chinese Herbal; Glycosides; Humans; Liver Neoplasms; Male; Mice; Rats; Rats, Sprague-Dawley; Steroids; Tandem Mass Spectrometry; Tissue Distribution | 2015 |
Anticancer effect of caudatin in diethylnitrosamine‑induced hepatocarcinogenesis in rats.
Topics: Activating Transcription Factor 4; Activating Transcription Factor 6; Animals; Antineoplastic Agents; Cytokines; Diethylnitrosamine; eIF-2 Kinase; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Glycosides; Heat-Shock Proteins; Liver; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Rats, Sprague-Dawley; Signal Transduction; Steroids; Unfolded Protein Response | 2020 |